Notice to Extend the Expiration Date for PAR-25-095 "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)"
Notice Number:
NOT-CA-26-011

Key Dates

Release Date:

May 28, 2026

Related Announcements

  • November 18, 2024 - Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed). See PAR-25-095

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to extend the expiration date for PAR-25-095, "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)".

Therefore, with the addition/extension by one Application Due Date, PAR-25-095 now expires on November 6, 2026.

The following sections in Part 1. Overview Information, Key Dates section have been changed:  

Currently reads and modified to read (in bold italics):

New

Renewal/

Resubmission/

Revision

AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
February 5, 2025March 5, 2025Not ApplicableJuly 2025October 2025December 2025
June 5, 2025July 5, 2025Not ApplicableNovember 2025January 2026April 2026
October 5, 2025November 5, 2025Not ApplicableMarch 2026May 2026July 2026
February 5, 2026March 5, 2026Not ApplicableJuly 2026October 2026December 2026
June 5, 2026July 5, 2026Not ApplicableNovember 2026January 2027April 2027
October 5, 2026November 5, 2026Not ApplicableMarch 2027May 2027July 2027

Currently reads:

Expiration Date: September 08, 2026

Modified to read (in italics):

Expiration Date: November 6, 2026

All other aspects of PAR-25-095 remain unchanged.

Inquiries

Please direct all inquiries to: